Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Is Estimated To Witness High Growth Owing To Increasing Approvals of Novel Drugs
by The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market is estimated to be valued at -2030 US$ 972.22 million in 2022 and is expected to exhibit a …